vs
MERCANTILE BANK CORP（MBWM）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
MERCANTILE BANK CORP的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.2倍（$67.6M vs $57.3M），MERCANTILE BANK CORP净利率更高（33.6% vs -83.0%，领先116.5%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 9.1%）
泰米尔纳德商业银行（TMB）是一家印度银行，总部位于泰米尔纳德邦杜蒂戈林。该行始建于1921年，最初名为纳达尔银行，1962年11月更名为泰米尔纳德商业银行，以拓展纳达尔社群以外的业务。目前该银行在印度全境拥有600家全功能网点、12个区域办事处及各类配套服务中心与自助设施。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
MBWM vs RYTM — 直观对比
营收规模更大
MBWM
是对方的1.2倍
$57.3M
净利率更高
MBWM
高出116.5%
-83.0%
两年增速更快
RYTM
近两年复合增速
9.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.6M | $57.3M |
| 净利润 | $22.7M | $-47.5M |
| 毛利率 | — | 91.6% |
| 营业利润率 | — | -82.2% |
| 净利率 | 33.6% | -83.0% |
| 营收同比 | — | 36.9% |
| 净利润同比 | 16.1% | -9.6% |
| 每股收益（稀释后） | $1.32 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MBWMRYTM
| Q1 26 | $67.6M | — | ||
| Q4 25 | $62.1M | $57.3M | ||
| Q3 25 | $62.4M | $51.3M | ||
| Q2 25 | $60.9M | $48.5M | ||
| Q1 25 | $57.3M | $32.7M | ||
| Q4 24 | $58.5M | $41.8M | ||
| Q3 24 | $58.0M | $33.3M | ||
| Q2 24 | $56.8M | $29.1M |
净利润MBWMRYTM
| Q1 26 | $22.7M | — | ||
| Q4 25 | $22.8M | $-47.5M | ||
| Q3 25 | $23.8M | $-52.9M | ||
| Q2 25 | $22.6M | $-46.6M | ||
| Q1 25 | $19.5M | $-49.5M | ||
| Q4 24 | $19.6M | $-43.3M | ||
| Q3 24 | $19.6M | $-43.6M | ||
| Q2 24 | $18.8M | $-32.3M |
毛利率MBWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
营业利润率MBWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | 42.0% | -82.2% | ||
| Q3 25 | 44.0% | -102.6% | ||
| Q2 25 | 42.6% | -93.4% | ||
| Q1 25 | 42.0% | -143.7% | ||
| Q4 24 | 39.7% | -98.6% | ||
| Q3 24 | 42.4% | -132.0% | ||
| Q2 24 | 41.4% | -139.2% |
净利率MBWMRYTM
| Q1 26 | 33.6% | — | ||
| Q4 25 | 36.8% | -83.0% | ||
| Q3 25 | 38.1% | -103.1% | ||
| Q2 25 | 37.1% | -96.1% | ||
| Q1 25 | 34.1% | -151.4% | ||
| Q4 24 | 33.5% | -103.6% | ||
| Q3 24 | 33.8% | -131.2% | ||
| Q2 24 | 33.1% | -110.9% |
每股收益（稀释后）MBWMRYTM
| Q1 26 | $1.32 | — | ||
| Q4 25 | $1.41 | $-0.73 | ||
| Q3 25 | $1.46 | $-0.82 | ||
| Q2 25 | $1.39 | $-0.75 | ||
| Q1 25 | $1.21 | $-0.81 | ||
| Q4 24 | $1.20 | $-0.71 | ||
| Q3 24 | $1.22 | $-0.73 | ||
| Q2 24 | $1.17 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $388.9M |
| 总债务越低越好 | $1.5M | — |
| 股东权益账面价值 | $736.9M | $139.1M |
| 总资产 | $6.9B | $480.2M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资MBWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M |
总债务MBWMRYTM
| Q1 26 | $1.5M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益MBWMRYTM
| Q1 26 | $736.9M | — | ||
| Q4 25 | $724.9M | $139.1M | ||
| Q3 25 | $657.6M | $148.8M | ||
| Q2 25 | $631.5M | $-11.9M | ||
| Q1 25 | $608.3M | $18.9M | ||
| Q4 24 | $584.5M | $21.7M | ||
| Q3 24 | $583.3M | $11.2M | ||
| Q2 24 | $551.2M | $39.3M |
总资产MBWMRYTM
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.8B | $480.2M | ||
| Q3 25 | $6.3B | $506.9M | ||
| Q2 25 | $6.2B | $372.7M | ||
| Q1 25 | $6.1B | $386.7M | ||
| Q4 24 | $6.1B | $392.3M | ||
| Q3 24 | $5.9B | $363.6M | ||
| Q2 24 | $5.6B | $381.8M |
负债/权益比MBWMRYTM
| Q1 26 | 0.00× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MBWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | $18.0M | $-25.4M | ||
| Q3 25 | $23.1M | $-26.6M | ||
| Q2 25 | $-7.8M | $-23.3M | ||
| Q1 25 | $-3.0M | $-40.4M | ||
| Q4 24 | $101.1M | $-18.8M | ||
| Q3 24 | $-8.1M | $-25.2M | ||
| Q2 24 | $9.1M | $-29.1M |
现金转化率MBWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | 0.79× | — | ||
| Q3 25 | 0.97× | — | ||
| Q2 25 | -0.35× | — | ||
| Q1 25 | -0.15× | — | ||
| Q4 24 | 5.15× | — | ||
| Q3 24 | -0.41× | — | ||
| Q2 24 | 0.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MBWM
| Net Interest Income | $55.9M | 83% |
| Noninterest Income | $11.7M | 17% |
RYTM
暂无分部数据
